SABCS 2022 - Early breast cancer year in revi ...

oncoXchange |

December 2022

SABCS 2022 - Antibody-drug conjugates were bl ...

oncoXchange |

December 2022

ASCO 2022 - Utility of genomics in HR-positiv ...

oncoXchange |

June 2022

ASCO 2022 - Gianni Bonadonna award lecture hi ...

oncoXchange |

June 2022

SABCS 2021: HR-positive, HER2-negative breast ...

oncoXchange |

December 2021

SABCS 2021: Data support T-DXd as second-line ...

oncoXchange |

December 2021

SABCS 2021 - ER-positive breast cancers have ...

oncoXchange |

December 2021

ESMO 2021 - MONALEESA-2: Ribociclib extends O ...

oncoXchange |

October 2021

ESMO 2021 - Immunotherapy, CDK4/6 inhibition ...

oncoXchange |

October 2021

ESMO 2021 - Immunotherapy but not PARP inhibi ...

oncoXchange |

September 2021